Professor Jennifer Hill is the Inaugural Bob Baxt AO Chair of Corporate and Commercial Law and Director of CLARS. Her scholarship on comparative corporate law and governance is widely cited in ...

Prof Langley was Deputy Editor of the Academy of Management Journal for qualitative research from 2022-2025, and co-editor of Strategic Organization from 2009 to 2022. She is also coeditor with ...

Located at Monash University’s Clayton campus, the Monash FutureLab is a globally-connected innovation hub that supports technological innovation and collaboration in material engineering, additive ...

Assessment Assessment Assessment Academic integrity Academic integrity Academic integrity Roles and responsibilities Roles and responsibilities Report a breach or misconduct Report a breach or ...

Global delegates and DFAT visit Monash to learn about new frontiers in neuroscience research and technology; Global delegates and DFAT visit M ...

The NCHA’s Digital Library is Australia’s first secure digitised collection of real-world consultations between GPs and their adult patients, plus related data: including anonymised transcripts, ...

Managed in collaboration with co-Trustees the Honourable Justice Debra Mullins AO (Chair), Paul de Silva, and Peter Evans, the Viertel Foundation was established with an initial bequest of $60 million ...

모나쉬 대학은 호주 유수의 명문 대학으로서 세계 100대 대학에 속합니다. 연구와 교육을 통해 삶을 바꾸는 변화를 지원합니다.

Your study options Part-time study Part-time study Mature age learning Mature age learning ...

Monash University has again demonstrated its national research leadership and the excellence of its researchers, securing 78 new Australian Research Council (ARC) Discovery Projects worth $62.8 ...

“Our earlier studies showed IC7Fc could help manage type 2 diabetes, a metabolic disease. This new research shows it can also reduce atherosclerosis, meaning it slows the ‘clogging’ of the arteries, ...

Antimicrobial resistance (AMR) is one of the world’s most urgent health challenges, with the WHO’s new report showing there are ‘too few antibacterials in the pipeline’. Most of the ‘low-hanging fruit ...